AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is announcing it’s already announced before.
www.marketwatch.com
#AstraZeneca #build #Virginia #plant #rehashes #U.S #investment #plans
AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
